title: The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation.
authors.affiliation: Department of Internal Medicine, The University of Texas Medical School at Houston, USA. vfriedew@nd.edu
authors.forename: Vincent E
authors.initials: VE
authors.lastname: Friedewald
authors.forename: Gregg C
authors.initials: GC
authors.lastname: Fonarow
authors.forename: Brian
authors.initials: B
authors.lastname: Olshansky
authors.forename: Clyde W
authors.initials: CW
authors.lastname: Yancy
authors.forename: William C
authors.initials: WC
authors.lastname: Roberts
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004502:Education, Medical, Continuing / Q000458:organization & administration; D006333:Heart Failure / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D011322:Primary Prevention / Q000379:methods; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000628:therapy*
chemical_list: D000889:Anti-Arrhythmia Agents